1.56 USD
↘ 0.02 (1.27%)AT CLOSE (AS OF 07:41 PM EDT)
InflaRx N.V. Common Stock
IFRXNASDAQ • USD
Market: CLOSED
IFRX is currently priced at $1.56. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. This is driven by a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Oct 7, 2026.
Open?$1.60
High?$1.60
Low?$1.55
Prev. Close?$1.58
Volume?460.4K
Avg. Volume?N/A
VWAP?$1.57
Bid / Ask
Bid?$1.55 × 200
Ask?$1.56 × 200
Spread?$0.01
Midpoint?$1.56
Valuation & Ratios
Market Cap?232.8M
Shares Out?14.9M
Float?137.9M
Float %?93.6%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?8.78%Elevated
Short Interest?12.1M
Days to Cover?23.1
Free Float137.9M
Avg Daily Volume524.8K
Settlement Date2026-09-15